Seven Eight Capital, LP Jazz Pharmaceuticals PLC Transaction History

Seven Eight Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$103.94 - $118.98 $668,542 - $765,279	6,432 New	6,432 $686,000
Q4 2023 Feb 13, 2024	BUY	$114.26 - $136.0 $1.09 Million - $1.3 Million	9,529 New	9,529 $1.17 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $3.07 Million - $3.51 Million	-24,517 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$125.55 - $144.48 $2.1 Million - $2.41 Million	-16,693 Reduced 40.51%	24,517 $3.5 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $3.3 Million - $3.87 Million	27,100 Added 192.06%	41,210 $5.89 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $1.64 Million - $2.35 Million	14,110 New	14,110 $1.75 Million
Q3 2017 Oct 16, 2017	SELL	$142.62 - $155.6 $641,790 - $700,200	-4,500 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	4,500	4,500 $700,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.